Anti-epileptics And Anti-depressants For Neuropathic Pain: Lessons From Cochrane Overviews And Systematic Reviews | 26848
ISSN: 2167-0846

Journal of Pain & Relief
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Anti-epileptics and anti-depressants for neuropathic pain: Lessons from Cochrane overviews and systematic reviews

International Conference and Exhibition on Pain Medicine

Phil Wiffen

Posters-Accepted Abstracts: J Pain Relief

DOI: 10.4172/2167-0846.S1.003

Anti-epileptics and anti-depressants are widely used to manage a variety of neuropathic pain conditions. Using wellestablished evidence based medicine approach a resume will be given of the development of overviews to summarize systematic reviews and make information more accessible to practitioners.The session will discuss the randomized controlled trial literature and present the results of two major Cochrane overviews on these classes of medicines. These show that not all anti-epileptics or anti-depressants are equal and that some of the mainstays of neuropathic pain treatments such as carbamazepine are largely unsupported by good quality evidence. The session will end with a view of the flaws in many of the published randomized trials together with some suggestions for grading evidence in order to stimulate higher quality research into effectiveness.